Yu X-Y, Zhou Z-W, Lin S-G, Chen X, Yu X-Q, Liang J, Duan W, Wen J-Y, Li X-T, Zhou S-F
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, China.
Xenobiotica. 2007 Apr;37(4):375-415. doi: 10.1080/00498250701230559.
There is an increasing use of herbal medicines worldwide, and the extracts from the root of Salvia miltiorrhiza are widely used in the treatment of angina and stroke. In this study, we investigated the mechanism for the intestinal absorption of tanshinone IIB (TSB), a major constituent of S. miltiorrhiza. The oral bioavailability of TSB was about 3% in rats with less proportional increase in its maximum plasma concentration (C(max)) and area under the plasma concentration-time curve (AUC) with increasing dosage. The time to C(max) (T(max)) was prolonged at higher oral dosage. In a single pass rat intestinal perfusion model, the permeability coefficients (P(app)) based on TSB disappearance from the lumen (P(lumen)) were 6.2- to 7.2-fold higher (p < 0.01) than those based on drug appearance in mesenteric venous blood (P(blood)). The uptake and efflux of TSB in Caco-2 cells were also significantly altered in the presence of an inhibitor for P-glycoprotein (PgP) or for multi-drug resistance associated protein (MRP1/2). TSB transport from the apical (AP) to basolateral (BL) side in Caco-2 monolayers was 3.3- to 5.7-fold lower than that from BL to AP side, but this polarized transport was attenuated by co-incubation of PgP or MRP1/2 inhibitors. The P(app) values of TSB in the BL-AP direction were significantly higher in MDCKII cells over-expressing MDR1 or MRP1, but not in cells over-expressing MRP2-5, as compared with the wild-type cells. The plasma AUC(0-24hr) in mdr1a and mrp1 gene-deficient mice was 10.2- to 1.7-fold higher than that in the wild-type mice. Furthermore, TSB significantly inhibited the uptake of digoxin and vinblastine in membrane vesicles containing PgP or MRP1. TSB also moderately stimulated PgP ATPase activity. Taken collectively, our findings indicate that TSB is a substrate for PgP and MRP1 and that drug resistance to TSB therapy and drug interactions may occur through PgP and MRP1 modulation.
全球范围内草药的使用日益增加,丹参根提取物被广泛用于治疗心绞痛和中风。在本研究中,我们研究了丹参主要成分丹参酮IIB(TSB)的肠道吸收机制。TSB在大鼠中的口服生物利用度约为3%,随着剂量增加,其最大血浆浓度(C(max))和血浆浓度-时间曲线下面积(AUC)的增加比例较小。较高口服剂量时达到C(max)的时间(T(max))延长。在大鼠单通道肠道灌注模型中,基于TSB从肠腔消失的通透系数(P(app))(P(lumen))比基于肠系膜静脉血中药物出现的通透系数(P(blood))高6.2至7.2倍(p < 0.01)。在存在P-糖蛋白(PgP)或多药耐药相关蛋白(MRP1/2)抑制剂的情况下,TSB在Caco-2细胞中的摄取和外排也发生了显著改变。TSB在Caco-2单层细胞中从顶端(AP)到基底外侧(BL)的转运比从BL到AP侧低3.3至5.7倍,但这种极化转运通过与PgP或MRP1/2抑制剂共同孵育而减弱。与野生型细胞相比,在过表达MDR1或MRP1的MDCKII细胞中,TSB在BL-AP方向的P(app)值显著更高,但在过表达MRP2 - 5的细胞中则不然。mdr1a和mrp1基因缺陷小鼠的血浆AUC(0 - 24hr)比野生型小鼠高10.2至1.7倍。此外,TSB显著抑制含有PgP或MRP1的膜囊泡中地高辛和长春碱的摄取。TSB还适度刺激PgP ATP酶活性。综上所述,我们的研究结果表明TSB是PgP和MRP1的底物,对TSB治疗的耐药性和药物相互作用可能通过PgP和MRP1调节而发生。